Beyond providing world-class storage, our commitment lies in ensuring that every stem cell unit maintains the highest viability for clinical use. To date, Thai StemLife has successfully completed over 25 clinical releases for therapeutic applications. This track record serves as a testament to our rigorous processing and cryopreservation protocols, meeting the highest international medical standards.
Hematopoietic stem cells in the bloodstream are blood-forming stem cells that continuously circulate in the body in small amounts. However, when the body receives cytokines that stimulate bone marrow activity, such as G-CSF (a naturally occurring factor that stimulates stem cell production), or during bone marrow recovery after chemotherapy, the number of these blood-forming stem cells in the bloodstream increases rapidly. Transplanting stem cells collected from the bloodstream tends to engraft more quickly than using stem cells from bone marrow, possibly because they contain more mature blood-forming stem cells. When we refer to ‘stem cell transplants,’ it usually means the transplantation of stem cells from the bloodstream. Although the natural habitat of stem cells is the bone marrow, we can induce them to exit the bone marrow and enter the bloodstream, where they can be collected more easily.
ปรึกษาแพทย์เกี่ยวกับประวัติการแพทย์และการตรวจร่างกาย
ฉีดยากระตุ้นการสร้างสเต็มเซลล์จากไขกระดูก (G-CSF) 5 วัน
เก็บFull PBSCs ด้วย apheresis AutoMini PBSCs ใช้เลือด 350 ซีซี
ส่งตัวอย่างไปยังห้องปฏิบัติการของTHAI StemLife เพื่อทำการคัดแยกและเพาะเลี้ยงสเต็มเซลล์
จัดเก็บสเต็มเซลล์ แช่เยือกแข็งที่อุณหภูมิ-196°C
เบิกสเต็มเซลล์เพื่อนำไปใช้
Nothing vouches better than a release and use of a Cord Blood unit in a successful bone marrow transplantation ultimately SAVING a LIFE, something that no other private stem cell bank in Thailand has accomplished.
THAI StemLife Cord Blood Release Record as of September 2022 Most releases by a SINGLE Stem Cell Bank in Thailand, SE Asia and the whole of Asia!
ASD: Autistic Spectrum Disorder; IEM: Inborn Errors of Metabolism; CP: Cerebral Palsy;
HIE: Hypoxic Ischemic Encephalopathy
MM: Multiple Myelome; MS: Multiple Sclerosis; ALL: Acute Lymphocytic Leukemia; OA: Osteoarthritis
40 Releases of Autologous PBSC to Self for Osteoarthritis treatments at Private Hospitals & Police General Hospital Thailand as part of our Thai Medical Council approved Osteoarthritis study that resulted in 6 peer reviewed international publications, to dated cited more than 108 times. 25 Releases of Autologous PBSC to Self for Diabetes Mellitus ulcer treatments at Private Hospitals.
Thailand as part of our NIA 2006 Top Innovation Award study. This list shows releases by THAI StemLife, to support the treatment of various diseases. This should not be used as a reference for the list of treatable diseases by stem cells. In addition, banking your baby’s cord blood/lining/tissue does not guarantee that the stem cells will provide a cure or be applicable for every situation. The use is ultimately determined by the treating physician.
Over 105 lives SAVED!
In 2007, THAI StemLife provided autologous umbilical cord blood stem cells along with G-CSF in CEREBRAL PALSY. Peer review publication in 2011; to date, cited internationally 60 times.
In 2008, THAI StemLife provided autologous peripheral blood stem cells to heal DIABETIC ULCERS.
In 2003, THAI StemLife provided Cord Blood Stem Cells from a SAVIOR sibling achieved through IVF at our sister company Superior ART, for Bone Marrow Transplantation in THALASSEMIA. To date, another 15 babies have been born at Superior ART and their cord blood stem cells have cured Thalassemia in 15 affected siblings to date! To date, 15 out of 100 successful cases worldwide have been provided by THAI StemLife
In 2009, we provided autologous peripheral blood stem cells for bone marrow transplantation in MULTIPLE SCLEROSIS (MS).
We provided autologous peripheral blood stem cells for studies in KNEE OSTEOARTHRITIS since 2013. All our six publications have been cited internationally over 140 times!
In 2014, we studied how autologous peripheral blood stem cells work in CARTILAGE REGENERATION in 2014. Our publication has been cited internationally 42 times!
In 2017, we conducted a randomized controlled study of autologous peripheral blood stem cells in KNEE OSTEOARTHRITIS that was approved by the Thai Ministry of Public Health and the Thai Medical Council. Our publication has been cited internationally 28 times!
Address: 566/3 Soi Ramkhamhaeng 39 (Thepleela 1), Prachaouthit Rd., Wangthonglang, Wangthonglang, Bangkok 10310.
Subscribe to get notified about product launches, special offers and company news.
ไทย
